Advanced search
Publication Cover
Cancer Management and Research Volume 13, 2021 - Issue
Submit an article Journal homepage
66
Views
2
CrossRef citations to date
0
Altmetric
Original Research

The Maturation of Tumor Suppressor miR-497 in Hepatocellular Carcinoma is Inhibited by Oncogenic circRNA SCARB1

Shuo Zhu1 Department of Hepatobiliary Surgery, Xuzhou Cancer Hospital, Xuzhou City, Jiangsu Province, 221000, People’s Republic of China
,
Shengya Cao2 Department of Clinical Laboratory, Xuzhou Cancer Hospital, Xuzhou City, Jiangsu Province, 221000, People’s Republic of China
,
Weibin Yang1 Department of Hepatobiliary Surgery, Xuzhou Cancer Hospital, Xuzhou City, Jiangsu Province, 221000, People’s Republic of China
,
Jinhui Che1 Department of Hepatobiliary Surgery, Xuzhou Cancer Hospital, Xuzhou City, Jiangsu Province, 221000, People’s Republic of China
,
Deqiang Li1 Department of Hepatobiliary Surgery, Xuzhou Cancer Hospital, Xuzhou City, Jiangsu Province, 221000, People’s Republic of China
,
Ruifeng Pei1 Department of Hepatobiliary Surgery, Xuzhou Cancer Hospital, Xuzhou City, Jiangsu Province, 221000, People’s Republic of China
&
Yiren Ding1 Department of Hepatobiliary Surgery, Xuzhou Cancer Hospital, Xuzhou City, Jiangsu Province, 221000, People’s Republic of ChinaCorrespondence[email protected]
 show all
Pages 5751-5759 | Published online: 16 Jul 2021

References

  • Yang JD , Roberts LR . Hepatocellular carcinoma: a global view. Nat Rev Gastroenterol Hepatol . 2010;7:448–458. doi:10.1038/nrgastro.2010.100 20628345
  • Njei B , Rotman Y , Ditah I , et al. Emerging trends in hepatocellular carcinoma incidence and mortality. Hepatology . 2015;61:191–199. doi:10.1002/hep.27388 25142309
  • Altekruse SF , Henley SJ , Cucinelli JE , et al. Changing hepatocellular carcinoma incidence and liver cancer mortality rates in the United States. Am J Gastroenterol . 2014;109:542–553. doi:10.1038/ajg.2014.11 24513805
  • Venook AP , Papandreou C , Furuse J , et al. The incidence and epidemiology of hepatocellular carcinoma: a global and regional perspective. Oncologist . 2010;15:5–13. doi:10.1634/theoncologist.2010-S4-05
  • Altekruse SF , McGlynn KA , Dickie LA , et al. Hepatocellular carcinoma confirmation, treatment, and survival in surveillance, epidemiology, and end results registries, 1992–2008. Hepatology . 2012;55:476–482. doi:10.1002/hep.24710 21953588
  • Tsuchiya N , Sawada Y , Endo I , et al. Biomarkers for the early diagnosis of hepatocellular carcinoma. World J Gastroenterol . 2015;21:10573–10583. doi:10.3748/wjg.v21.i37.10573 26457017
  • Arzumanyan A , Reis HM , Feitelson MA . Pathogenic mechanisms in HBV-and HCV-associated hepatocellular carcinoma. Nat Rev Cancer . 2013;13:123–135. doi:10.1038/nrc3449 23344543
  • El-Serag HB . Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology . 2012;142:1264–1273. e1. doi:10.1053/j.gastro.2011.12.061 22537432
  • Alqahtani A , Khan Z , Alloghbi A , et al. Hepatocellular carcinoma: molecular mechanisms and targeted therapies. Medicina . 2019;55:526. doi:10.3390/medicina55090526
  • Ding XX , Zhu QG , Zhang SM , et al. Precision medicine for hepatocellular carcinoma: driver mutations and targeted therapy. Oncotarget . 2017;8:55715–55730. doi:10.18632/oncotarget.18382 28903454
  • Thillai K , Ross P , Sarker D . Molecularly targeted therapy for advanced hepatocellular carcinoma – a drug development crisis? World J Gastrointest Oncol . 2016;8:173–185. doi:10.4251/wjgo.v8.i2.173 26909132
  • Patop IL , Kadener S . circRNAs in cancer. Curr Opin Genet Dev . 2018;48:121–127. doi:10.1016/j.gde.2017.11.007 29245064
  • Meng S , Zhou H , Feng Z , et al. CircRNA: functions and properties of a novel potential biomarker for cancer. Mol Cancer . 2017;23:94. doi:10.1186/s12943-017-0663-2
  • Hansen TB , Jensen TI , Clausen BH , et al. Natural RNA circles function as efficient microRNA sponges. Nature . 2013;495:384–388. doi:10.1038/nature11993 23446346
  • Sun J , Pan S , Cui H , et al. CircRNA SCARB1 promotes renal cell carcinoma progression via miR-510-5p/SDC3 axis. Curr Cancer Drug Targets . 2020;20(6):461–470. doi:10.2174/1568009620666200409130032 32271695
  • Yan JJ , Zhang YN , Liao JZ , et al. MiR-497 suppresses angiogenesis and metastasis of hepatocellular carcinoma by inhibiting VEGFA and AEG-1. Oncotarget . 2015;6:29527–29542. doi:10.18632/oncotarget.5012 26336827
  • Zhang M , Wu J , Zhang R , et al. miR-497 inhibits the carcinogenesis of hepatocellular carcinoma by targeting the Rictor/Akt signal pathway. Int J Clin Exp Pathol . 2019;12:1992–2000.31934021
  • Ding Q , He K , Luo T , et al. SSRP1 contributes to the malignancy of hepatocellular carcinoma and is negatively regulated by miR-497. Mol Ther . 2016;24:903–914. doi:10.1038/mt.2016.9 26755331
  • Achkar NP , Cambiagno DA , Manavella PA . miRNA biogenesis: a dynamic pathway. Trends Plant Sci . 2016;21:1034–1044. doi:10.1016/j.tplants.2016.09.003 27793495

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.